Abstract:Background: Only a small percentage of patients with large hepatocellular carcinoma (HCC) can undergo surgical resection (SR) therapy while the prognosis of patients with large HCC is poor. However, innovations in surgical techniques have expanded the scope of surgical interventions accessible to patients with large HCC. Currently, most of the existing nomograms are focused on patients with large HCC, and research on patients who undergo surgery is limited. This study aimed to establish a nomogram to predict cancer-specific survival (CSS) in patients with large HCC who will undergo SR. Methods: The study retrieved data from the Surveillance, Epidemiology, and End Results (SEER) database encompassing patients with HCC between 2010 and 2015. Patients with large HCC accepting SR were eligible participants. Patients were randomly divided into the training (70%) and internal validation (30%) groups. Patients from Air Force Medical Center between 2012 and 2019 who met the inclusion and exclusion criteria were used as external datasets. Demographic information such as sex, age, race, etc. and clinical characteristics such as chemotherapy, histological grade, fibrosis score, etc. were analyzed. CSS was the primary endpoint. All-subset regression and Cox regression were used to determine the relevant variables required for constructing the nomogram. Decision curve analysis (DCA) was used to evaluate the clinical utility of the nomogram. The area under the receiver operating characteristic curve (AUC) and calibration curve were used to validate the nomogram. The Kaplan-Meier curve was used to assess the CSS of patients with HCC in different risk groups. Results: In total, 1,209 eligible patients from SEER database and 21 eligible patients from Air Force Medical Center were included. Most patients were male and accepted surgery to lymph node. The independent prognostic factors included sex, histological grade, T stage, chemotherapy, α-fetoprotein (AFP) level, and vascular invasion. The CSS rate for training cohort at 12, 24, and 36 months were 0.726, 0.731, and 0.725 respectively. The CSS rate for internal validation cohort at 12, 24, and 36 months were 0.785, 0.752, and 0.734 respectively. The CSS rate for external validation cohort at 12, 24, and 36 months were 0.937, 0.929, and 0.913 respectively. The calibration curve demonstrated good consistency between the newly established nomogram and real-world observations. The Kaplan-Meier curve showed significantly unfavorable CSS in the high-risk group (P<0.001). DCA demonstrated favorable clinical applicability of the nomogram. Conclusions: The nomogram constructed based on sex, histological grade, T stage, chemotherapy and AFP levels can predict the CSS in patients with large HCC accepting SR, which may aid in clinical decision-making and treatment.

Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study

Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma

Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma

Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma

Metroticket approach in a retrospective cohort study to predict overall survival after surgical resection for intermediate stage hepatocellular carcinoma

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma

Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma

Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China

Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER database

Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular Carcinoma

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy

Development and Validation of a Prognostic Score Predicting Recurrence in Resected Combined Hepatocellular Cholangiocarcinoma

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection

Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus

Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection

Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma

Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study

Prediction of Survival and Analysis of Prognostic Factors for Patients With Combined Hepatocellular Carcinoma and Cholangiocarcinoma: A Population-Based Study

Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients